Zhao Lab advances drug development and regulatory science through cutting-edge research in pharmacometrics, drug delivery modeling, and artificial intelligence (AI)-based tools. These advances have been used in professional drug development and regulatory decision-making. Recent advances in the lab are looking to leverage Real World Evidence (RWE) to develop novel AI solutions for clinical tasks.